• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease

    Aural Analytics' Speech Analytics Software for ALS Gains Breakthrough Status

    Bigfoot Biomedical Acquires Insulin Titration Algorithm from McGill

    Apply Now: Junkosha's Technology Innovator of the Year Awards 2023

    SIS Medical's OPN NC PTCA Dilatation Catheter Released in U.S.
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Timeline Mystery for Updated EtO Rules

    An Update on Hospital Trends Post-Pandemic

    Don’t Fear the Audit: Benefits of Good Quality Practices

    Understanding the FDA’s Standards & Conformity Assessment Program

    Medtech Divestitures Are Good for Medtech Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Halkey-Roberts Corporation

    Cirtec Medical

    Fusion Biotec Inc.

    Forefront Medical Technology

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Designing for Manufacturing: 5 Common Startup Mistakes (and How to Avoid Them)

    5 Challenges Medtech Must Address to Transform Healthcare

    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Halkey-Roberts Corporation

    Cirtec Medical

    Fusion Biotec Inc.

    Forefront Medical Technology

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    An Overview of the ASCA Pilot Program

    The FDA published a three-part final guidance on the voluntary program.

    An Overview of the ASCA Pilot Program
    The ASCA Pilot program was set up to foster an accredited conformity assessment arrangement between medical device manufacturers, accreditation bodies, and testing laboratories. Image courtesy of MasterControl.
    David Jensen, Staff Writer, MasterControl03.11.21
    In September 2019, the U.S. Food and Drug Administration (FDA) Center for Device and Radiological Health (CDRH) introduced the Accreditation Scheme for Conformity Assessment (ASCA) Pilot. The program was set up to foster an accredited conformity assessment arrangement between medical device manufacturers, accreditation bodies, and testing laboratories. After receiving comments from the public and industry stakeholders, the FDA released its final guidance for the ASCA Pilot in September 2020.
     
    The Purpose of the ASCA Pilot
    In a nutshell, the FDA intends for the ASCA Pilot to use accredited, third-party testing laboratories to assess the declaration of conformity (DOC) provided by medical device manufacturers in their premarket submissions. These assessments will determine the company’s adherence to the agency’s consensus standards for safety, performance, and biocompatibility.
     
    The voluntary pilot program is designed to help make medical device and in vitro diagnostic (IVD) product premarket reviews more consistent and efficient. The agency also intends for the program to reduce the regulatory burden on device manufacturers by increasing product reviewers’ trust in medical device testing.
     
    ASCA Pilot Final Guidance
    The final guidance for the ASCA Pilot is considerably more comprehensive than the original draft. One notable variance is it includes an expanded section on the policies and processes involved in testing products. For example, guidelines regarding the organizational structure, environmental conditions, and resources of the testing laboratories include:
     
    • Ensuring staff is qualified and continually trained on methods to conduct testing within the scope of the regulations and standards.
    • Implementing procedures for governing the development, maintenance, and use of tests.
    • Maintaining testing equipment to ensure it remains in proper working order according to the accreditation requirements.
    • Setting up procedures for identifying testing errors caused by incorrect calibration or operation of equipment that could affect the accuracy and reliability of testing results.
    • Documenting and reporting all required information as detailed in ISO/IEC 17025.
     
    The FDA’s final guidance for the ASCA Pilot is dispersed across three guidance documents:
     
    • Goals and implementation of ASCA Pilot
    • Basic safety and essential performance standards
    • Biocompatibility testing of medical devices
     
    This article highlights aspects of each guidance that apply to medical device manufacturers and accredited testing laboratories participating in the ASCA Pilot.
     
    #1: ASCA Pilot – Goals and Implementation
    When the FDA first set up the ASCA Pilot in September 2019, the agency set goals for how the program will support its ongoing efforts to use its scientific resources effectively and efficiently to protect and promote public health.
     
    • Enhance confidence in medical device testing – Includes application processes and periodic audits of ASCA-recognized accreditation bodies to ensure they meet the criteria specified by the FDA.
    • Promote consistency and predictability in the premarket review process – The FDA’s commitment to clearly communicate expectations for how results from ASCA-accredited testing laboratories will be included and reviewed in premarket submissions.
    • Encourage effective use of FDA resources – Enlisting third-party organizations to participate in assessing the declaration of conformity (DOC) submissions from manufacturers allows the FDA to devote scientific and regulatory resources to other pertinent priorities.
    • Enhance regulatory efficiency – The FDA expects the application process, periodic audits, and clear communication among participants in the ASCA Pilot will decrease the need for additional information regarding testing methodologies, which will help speed up the submission process.
    • Support international harmonization – In developing the ASCA Pilot, the FDA used elements from international conformity assessment standards in the ISO/IEC 17000 series. In addition, most of the FDA-recognized consensus standards and test methods selected for the ASCA Pilot are international consensus standards.
     
    Medical device manufacturers can use testing performed by an ASCA-accredited testing laboratory to support their premarket submission as long as the laboratory uses an FDA-recognized consensus standard.
     
    #2: Basic Safety and Essential Performance Standards
    This segment of the guidance addresses the responsibilities of accredited laboratories in developing test plans and procedures. For example, tests should be project-specific and include documentation of test details the FDA has itemized in the guidance, such as:
     
    • Test identification information, including title, document number, revision, and effective date
    • Specific test equipment required
    • Warning/caution statements to alert operators of potential hazards
    • Normal and/or unusual ambient conditions, including tolerances for tests
    • Test data to be obtained and recorded
    • Objective acceptance criteria
     
    The guidance includes guidelines for inspecting the manufacturer’s risk management file to obtain objective evidence. Laboratories must also provide a list of all documents examined during the inspection.
     
    #3: Biocompatibility Testing of Medical Devices
    Finally, regulatory bodies are committed to the protection of patient safety. That said, biocompatibility, which involves screening new medical devices for the possibility of patients experiencing adverse reactions, is a pivotal component of the ASCA Pilot.
     
    To comply with the biocompatibility requirements, participant accredited bodies must conform to guidelines in the ISO/IEC 17025 standard, which explains how laboratories need to demonstrate that they operate competently and generate valid results.
     
    In addition, this segment of the guidance states that “all testing should be conducted considering the recommendations in the CDRH Biocompatibility policy as described in the FDA’s guidance ‘Use of International Standard ISO 10993-1.’” The agency created this guidance to assist medical device manufacturers with preparing premarket applications for devices that have direct or indirect contact with the human body. It advises manufacturers on using risk-based approaches to determine if biocompatibility is needed.
     
    Conclusion
    The ASCA Pilot is voluntary. Device manufacturers that choose to use an ASCA-accredited testing laboratory to conduct testing are responsible for including the appropriate information regarding device testing in their premarket submissions. The FDA is still building the ASCA Pilot. As with other pilot programs, the agency will determine at a future date if more regulations, legislation, and public input will be needed before transitioning the ASCA Pilot to a permanent program.


    David Jensen is a staff writer for MasterControl.
    Suggested For You
    RJG RJG
    Web Industries Inc. Web Industries Inc.
    Nissha Medical Technologies Nissha Medical Technologies
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    Critical Software Solutions Critical Software Solutions
    WuXi AppTec Medical Device Testing WuXi AppTec Medical Device Testing
    DDL Inc. DDL Inc.
    sfm medical devices GmbH sfm medical devices GmbH
    Hangsterfer Hangsterfer's Laboratories
    Simbex Simbex
    Anjon Medical Technologies Anjon Medical Technologies
    IMA Automation North America IMA Automation North America
    Auriga Inc. Auriga Inc.
    WESTPAK Inc. WESTPAK Inc.
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions

    Related Buyers Guide Companies

    • RJG

      RJG

      ...
      Kara Eskeli 11.21.22

    • Web Industries Inc.

      ...
      Blake Phillips, Marketing Specialst 11.18.22

    • Nissha Medical Technologies

      ...
      Amy Jeary, Market Development Manager 11.18.22


    • JK Medirise-Disposable Medical Device Company

      ...
      Ketan Munjani, Marketing Manager 11.17.22

    • Critical Software Solutions

      ...
      Allen Curtis, CTO 11.16.22

    Loading, Please Wait..

    Trending
    • Medinbox And Abbott Partner To Increase Efficiency In Electrophysiology Labs
    • Masimo Reveals Freedom Health-Tracking Smartwatch
    • FDA OKs FemDx Medsystems' FalloView Device
    • Getinge’s Cardiosave Faces CE-Certificate Suspension From TÜV SÜD
    • A New Approach To Post-Market Surveillance
    Breaking News
    • FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
    • Aural Analytics' Speech Analytics Software for ALS Gains Breakthrough Status
    • Bigfoot Biomedical Acquires Insulin Titration Algorithm from McGill
    • Apply Now: Junkosha's Technology Innovator of the Year Awards 2023
    • SIS Medical's OPN NC PTCA Dilatation Catheter Released in U.S.
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Sensing Technology Drives the Future of Medical Care
    • New and Developing Diabetes Technologies Offer 'Sweet Relief'
    • Discussing Matters of Substance in Medtech Materials
    • Medical Device Testers Are Caught Up in a Whirlwind
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kemin Human Nutrition & Health Acquires Oral Health Ingredient
    Wiley Eliminates Outer Carton From Packaging to Reduce Waste
    ACG Expands as Vantage Nutrition Acquires ComboCap and its Dual-Chamber Capsule Technology
    Coatings World

    Latest Breaking News From Coatings World

    PPG Names Rodolfo Ramirez GM, Packaging Coatings
    Sherwin-Williams Unveils High Performance Interior Marine Decking Systems
    AkzoNobel Appoints Ricardo Rosso as Pontiac Site Manager
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
    Aural Analytics' Speech Analytics Software for ALS Gains Breakthrough Status
    Bigfoot Biomedical Acquires Insulin Titration Algorithm from McGill
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Thermo Fisher, Arsenal Biosciences Partner to Manufacture Autologous T-Cell Therapies
    Aquestive Therapeutics Expands Libervant License/Supply Agreement with Pharmanovia
    OncoVent, Orient EuroPharma Enter License Agreement for Oregovomab
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    GK Launches Vegan Hair Styling Range
    Sexual Wellness Brand Playground Recruits Christina Aguilera
    Buttah Skin Founder Wins Emerging Brand Partner of the Year Award from Macy’s
    Happi

    Latest Breaking News From Happi

    Kao Launches Space Shampoo Sheet for Haircare
    Procter & Gamble Brings Tide Relief Project to Mississippi Tornado Victims
    Cleaning Industry Leaders Head To Capitol Hill on March 29
    Ink World

    Latest Breaking News From Ink World

    INX International Makes Investment in Gooten
    Videojet Launches 1580 C Soft-Pigmented Contrast Printer
    Epson to Showcase Textile, Signage and Aqueous Printers at ISA 2023
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    AWA announces first International Linerless Label Conference
    Apex partners with MicroDynamics for anilox quality control
    Industrias Omega adds Durst Tau RSC E
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Toray Awarded for Nanodesign Technology
    SharpCell Launches Plastic-free Airlaid Material for Premium Napkins
    Suominen Offers Biolace Ultrasoft
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Collagen Matrix Rebrands to Regenity Biosciences
    OsteoBoost Study Yields Positive Results
    Conventus Flower Ortho Appoints Jeff Culhane as COO
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Universal Display Sponsors, Presents at ICDT 2023
    Miron Washington Joins Impinj Board of Directors
    All-Time High for Global 300MM Semiconductor Capacity in 2026: SEMI

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login